See All Slides - tctmd.com

Slides

Presentation TVT 2015

A Surgeons View: Will I Be in the Room in the Future?

Presenter: Susheel K. Kodali, David A. Wood, Michael J. Reardon

June 06, 2015

Presentation

Complete Revascularization in STEMI and Multivessel Disease

Presenter: M. Kowalewski

June 10, 2015

Presentation

Predictors of Bleeding in ACS Patients Treated With Prasugrel

Presenter: P. Widimsky

June 19, 2015

Presentation

Recurrent Cerebral Ischemia After PFO Closure in Older Patients

Presenter: Paolo Scacciatella

July 07, 2015

Presentation CCVVC 2015

Economics of Drug-Coated Technology in PAD

Presenter: Mark W. Burket

June 17, 2015

Presentation CCVVC 2015

Covered Stents in Femoropopliteal Disease

Presenter: Subhash Banerjee

June 18, 2015

Presentation TCT 2015

Introduction: A Critical Appraisal of Culprit Only vs Multivessel Intervention in STEMI Targets, Guidance, Data Review, and Future Directions

Presenter: Thomas Engstroem, Barry D. Rutherford, Shamir R. Mehta

October 11, 2015

Presentation TCT 2015

Debate 1: Should Cangrelor or an Oral ADP Antagonist Be Used in Most STEMI Patients? Oral or Crushed Ticagrelor for All!

Presenter: C. Michael Gibson, Marco Valgimigli, Guido Parodi

October 11, 2015

Presentation TCT 2015

The Spectrum of Hemodynamic Support Options for Cardiogenic Shock II: Are Any of Them Useful (Data Review and Personal Perspectives)?

Presenter: Cindy L. Grines, Simon Redwood, Holger Thiele

October 11, 2015

Presentation TCT 2015

Everything You Wanted to Know About Endovascular Radiation Hazards but Were Afraid to Ask

Presenter: Gary M. Ansel, Michael R. Jaff, Lindsay S. Machan

October 11, 2015

Advertisement

Slides

A Surgeons View: Will I Be in the Room in the Future?

Complete Revascularization in STEMI and Multivessel Disease

Predictors of Bleeding in ACS Patients Treated With Prasugrel

Recurrent Cerebral Ischemia After PFO Closure in Older Patients

Economics of Drug-Coated Technology in PAD

Covered Stents in Femoropopliteal Disease

Introduction: A Critical Appraisal of Culprit Only vs Multivessel Intervention in STEMI Targets, Guidance, Data Review, and Future Directions

Debate 1: Should Cangrelor or an Oral ADP Antagonist Be Used in Most STEMI Patients? Oral or Crushed Ticagrelor for All!

The Spectrum of Hemodynamic Support Options for Cardiogenic Shock II: Are Any of Them Useful (Data Review and Personal Perspectives)?

Everything You Wanted to Know About Endovascular Radiation Hazards but Were Afraid to Ask

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content